Literature DB >> 2333470

Cellular fibronectin in rheumatoid synovium and synovial fluid: a possible factor contributing to lymphocytic infiltration.

T K Walle1, T Vartio, T Helve, I Virtanen, P Kurki.   

Abstract

Mouse monoclonal antibodies against ED sequence-containing cellular fibronectin (cFn) were used to show that Fn in the inflamed synovium is distinct from the major form of plasma Fn (pFn). An accumulation of cFn was seen at sites of hyperplasia of the rheumatoid synovial membrane and in the walls of small vessels in the synovium by immunofluorescence microscopy. cFn was also found in rheumatoid synovial fluid by immunoblotting. Approximately one-fifth of the T lymphocytes from rheumatoid synovial fluid bound to Fn. The binding of synovial fluid T cells was always higher than that from peripheral blood. These results have two implications. On the one hand, the cellular type of Fn may be an indicator of synovial inflammation. On the other hand, the deposition of Fn may be a factor contributing to the infiltration of mononuclear cells into the synovium.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2333470     DOI: 10.1111/j.1365-3083.1990.tb02802.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  9 in total

1.  Fibronectin and circulating immune complexes in Behet's disease.

Authors:  K Ozoran; N Düzgün; H Tutkak; A Gürler; G Tokgöz
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

2.  Synovial fluid cells in juvenile arthritis: evidence of selective T cell migration to inflamed tissue.

Authors:  E D Silverman; B Isacovics; D Petsche; R M Laxer
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

3.  Localisation of fibronectin mRNA in the rheumatoid synovium by in situ hybridisation.

Authors:  H A Waller; M G Butler; J G McClean; G S Dowd; D L Scott
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

4.  Expression of fibronectin splice variants and oncofetal glycosylated fibronectin in the synovial membranes of patients with rheumatoid arthritis and osteoarthritis.

Authors:  J Kriegsmann; A Berndt; T Hansen; L Borsi; L Zardi; R Bräuer; P K Petrow; M Otto; C J Kirkpatrick; S Gay; H Kosmehl
Journal:  Rheumatol Int       Date:  2003-04-24       Impact factor: 2.631

5.  Local interleukin-1-driven joint pathology is dependent on toll-like receptor 4 activation.

Authors:  Shahla Abdollahi-Roodsaz; Leo A B Joosten; Marije I Koenders; Ben T van den Brand; Fons A J van de Loo; Wim B van den Berg
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

6.  Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis.

Authors:  Shahla Abdollahi-Roodsaz; Leo A B Joosten; Marije I Koenders; Isabel Devesa; Mieke F Roelofs; Timothy R D J Radstake; Marleen Heuvelmans-Jacobs; Shizuo Akira; Martin J H Nicklin; Fátima Ribeiro-Dias; Wim B van den Berg
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

Review 7.  Toll-Like Receptors in the Pathogenesis of Autoimmune Diseases.

Authors:  Akbar Mohammad Hosseini; Jafar Majidi; Behzad Baradaran; Mehdi Yousefi
Journal:  Adv Pharm Bull       Date:  2015-12-31

8.  Toll/Interleukin-1 Receptor Domain Derived from TcpC (TIR-TcpC) Ameliorates Experimental Autoimmune Arthritis by Down-modulating Th17 Cell Response.

Authors:  Shweta Pasi; Ravi Kant; Avadhesha Surolia
Journal:  J Biol Chem       Date:  2016-03-28       Impact factor: 5.157

9.  Citrullinated fibronectin inhibits apoptosis and promotes the secretion of pro-inflammatory cytokines in fibroblast-like synoviocytes in rheumatoid arthritis.

Authors:  Lieying Fan; Qiang Wang; Rongqing Liu; Ming Zong; Dongyi He; Hui Zhang; Yuanyuan Ding; Jianwei Ma
Journal:  Arthritis Res Ther       Date:  2012-12-10       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.